ACAD financials
Acadia Pharmaceuticals (ACAD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ACAD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $1.07B | $982.51M | $104.81M | $391.00M | 2.29 |
| 2024 | $957.80M | $875.96M | $230.79M | $226.45M | 1.36 |
| 2023 | $726.44M | $680.71M | -$73.38M | -$61.29M | -0.37 |
| 2022 | $517.24M | $507.07M | -$223.60M | -$215.97M | -1.34 |
| 2021 | $484.14M | $465.00M | -$170.44M | -$167.87M | -1.05 |
| 2020 | $441.75M | $421.20M | -$286.59M | -$281.58M | -1.79 |
- ACAD revenue was $1.07B in fiscal 2025, net income $391.00M.
Updated 2026-11-03 00:45 UTC